Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

137 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prognostic impact of secondary versus de novo ontogeny in acute myeloid leukemia is accounted for by the European LeukemiaNet 2022 risk classification.
Hochman MJ, Othus M, Hasserjian RP, Ambinder A, Brunner A, Percival MM, Hourigan CS, Swords R, DeZern AE, Estey EH, Karp JE. Hochman MJ, et al. Among authors: hourigan cs. Leukemia. 2023 Sep;37(9):1915-1918. doi: 10.1038/s41375-023-01985-y. Epub 2023 Jul 31. Leukemia. 2023. PMID: 37524919 Free PMC article.
A novel approach to antigen-specific deletion of CTL with minimal cellular activation using alpha3 domain mutants of MHC class I/peptide complex.
Xu XN, Purbhoo MA, Chen N, Mongkolsapaya J, Cox JH, Meier UC, Tafuro S, Dunbar PR, Sewell AK, Hourigan CS, Appay V, Cerundolo V, Burrows SR, McMichael AJ, Screaton GR. Xu XN, et al. Among authors: hourigan cs. Immunity. 2001 May;14(5):591-602. doi: 10.1016/s1074-7613(01)00133-9. Immunity. 2001. PMID: 11371361 Free article.
The molecular basis of coeliac disease.
Hourigan CS. Hourigan CS. Clin Exp Med. 2006 Jun;6(2):53-9. doi: 10.1007/s10238-006-0095-6. Clin Exp Med. 2006. PMID: 16820991 Review.
The human CD8 coreceptor effects cytotoxic T cell activation and antigen sensitivity primarily by mediating complete phosphorylation of the T cell receptor zeta chain.
Purbhoo MA, Boulter JM, Price DA, Vuidepot AL, Hourigan CS, Dunbar PR, Olson K, Dawson SJ, Phillips RE, Jakobsen BK, Bell JI, Sewell AK. Purbhoo MA, et al. Among authors: hourigan cs. J Biol Chem. 2001 Aug 31;276(35):32786-92. doi: 10.1074/jbc.M102498200. Epub 2001 Jul 3. J Biol Chem. 2001. PMID: 11438524 Free article.
Minimal residual disease in acute myeloid leukaemia.
Hourigan CS, Karp JE. Hourigan CS, et al. Nat Rev Clin Oncol. 2013 Aug;10(8):460-71. doi: 10.1038/nrclinonc.2013.100. Epub 2013 Jun 25. Nat Rev Clin Oncol. 2013. PMID: 23799371 Free PMC article. Review.
Personalized therapy for acute myeloid leukemia.
Hourigan CS, Karp JE. Hourigan CS, et al. Cancer Discov. 2013 Dec;3(12):1336-8. doi: 10.1158/2159-8290.CD-13-0832. Cancer Discov. 2013. PMID: 24327695 Free PMC article.
137 results